Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Squamous Cell Carcinoma (ESCC)

Clinical trial NCT07263919 · RECRUITING

Trial details

NCT number: NCT07263919
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Start date: 2025-12-19
Primary completion: 2030-03-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.